MedPlus Health Services Limited (MEDPLUS.NS)
NSE · INR · Healthcare · Pharmaceutical Retailers
₹621.45 (+2.19%) as of
Key statistics
- Market cap
- 74.63B
- P/E (TTM)
- 35.47
- Forward P/E
- 27.40
- EPS (TTM)
- 17.52
- Dividend yield
- 0.00%
- 52-week range
- 576.30 – 1,022.20
- Beta
- 0.46
- Revenue (TTM)
- 72.29B
- Profit margin
- 2.91%
- Analyst target
- ₹993.14
- Volume
- 66.85k
About MedPlus Health Services Limited
MedPlus Health Services Limited engages in the retail trading of medicines and general items in India. It manufactures and trades in pharmaceutical and wellness items, such as prescription medicines, over-the-counter drugs, vitamins, vitamins, medical devices, and diagnostic test kits; and fast-moving consumer goods (FMCG), including personal and home care products like toiletries, baby care items, soaps, detergents, and sanitizers. The company also engages in wholesale cash and carry; provision of diagnostic, pathological, and laboratory testing services, as well as contract manufacturing of private-label pharmaceuticals, wellness products, and FMCG goods; and operates diagnostic centres. It distributes its products through retail and online channels. The company was incorporated in 2006 and is based in Hyderabad, India.
- Sector
- Healthcare
- Industry
- Pharmaceutical Retailers
- Headquarters
- Hyderabad, India
- Employees
- 28,872
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.